Is Inogen, Inc.'s (NASDAQ:INGN) CEO Paid Enough Relative To Peers?

Scott Wilkinson became the CEO of Inogen, Inc. (NASDAQ:INGN) in 2017. First, this article will compare CEO compensation with compensation at similar sized companies. After that, we will consider the growth in the business. And finally - as a second measure of performance - we will look at the returns shareholders have received over the last few years. The aim of all this is to consider the appropriateness of CEO pay levels.

View our latest analysis for Inogen

Advertisement

How Does Scott Wilkinson's Compensation Compare With Similar Sized Companies?

According to our data, Inogen, Inc. has a market capitalization of US$1.0b, and paid its CEO total annual compensation worth US$2.7m over the year to December 2018. While we always look at total compensation first, we note that the salary component is less, at US$494k. We further remind readers that the CEO may face performance requirements to receive the non-salary part of the total compensation. We examined companies with market caps from US$400m to US$1.6b, and discovered that the median CEO total compensation of that group was US$2.7m.

So Scott Wilkinson receives a similar amount to the median CEO pay, amongst the companies we looked at. This doesn't tell us a whole lot on its own, but looking at the performance of the actual business will give us useful context.

You can see, below, how CEO compensation at Inogen has changed over time.

NasdaqGS:INGN CEO Compensation, September 13th 2019
NasdaqGS:INGN CEO Compensation, September 13th 2019

Is Inogen, Inc. Growing?

Inogen, Inc. has increased its earnings per share (EPS) by an average of 32% a year, over the last three years (using a line of best fit). In the last year, its revenue is up 21%.

This demonstrates that the company has been improving recently. A good result. It's also good to see decent revenue growth in the last year, suggesting the business is healthy and growing.

Has Inogen, Inc. Been A Good Investment?

With a three year total loss of 22%, Inogen, Inc. would certainly have some dissatisfied shareholders. This suggests it would be unwise for the company to pay the CEO too generously.

In Summary...

Scott Wilkinson is paid around the same as most CEOs of similar size companies.

We like that the company is growing EPS, but it's disappointing to see negative shareholder returns over three years. Considering the the positives we don't think the CEO pays is too high, but it's certainly hard to argue it is too low. If you think CEO compensation levels are interesting you will probably really like this free visualization of insider trading at Inogen.

Arguably, business quality is much more important than CEO compensation levels. So check out this free list of interesting companies, that have HIGH return on equity and low debt.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

About NasdaqGS:INGN

Inogen

A medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.

Very undervalued with excellent balance sheet.

Advertisement

Weekly Picks

CE
Ceazar
CNXU logo
Ceazar on Conexeu Sciences ·

This small biotech is developing technology that could potentially change how tissue is rebuilt

Fair Value:US$25.3451.9% undervalued
52 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75035.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
TR
tripledub
INTU logo
tripledub on Intuit ·

A Wonderful Business at a Not-So-Wonderful Price

Fair Value:US$56054.0% undervalued
43 users have followed this narrative
1 users have commented on this narrative
26 users have liked this narrative
TA
Talos
HYFT logo
Talos on MindWalk Holdings ·

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect

Fair Value:US$8.2781.9% undervalued
8 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

AS
AstrisCorporateAdvisory
9556 logo
AstrisCorporateAdvisory on INTLOOP ·

Renewed focus on business investment

Fair Value:JPÂ¥4.17k61.0% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GE
HKB logo
Germaine on Hartanah Kenyalang Berhad ·

Hartanah Kenyalang Berhad (Bursa: 0359): A Hidden Gem in the Malaysian Construction Sector?

Fair Value:RM 0.13419.2% overvalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
JA
Jacobm2488123
NFLX logo
Jacobm2488123 on Netflix ·

Netflix's Revenue Surge Will Hit 18% Despite Market Lows

Fair Value:US$115.9137.1% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7443.8% undervalued
67 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9639.1% undervalued
61 users have followed this narrative
9 users have commented on this narrative
18 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17056.9% undervalued
51 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative